Literature DB >> 20420101

Survival time and prognostic factors of oral cancer in Ubon Ratchathani Cancer Center.

Watcharin Kruaysawat1, Wichai Aekplakorn, Robert S Chapman.   

Abstract

OBJECTIVE: To characterize the survival time and prognostic factors of oral cancer in Ubon Ratchathani, Thailand. MATERIAL AND
METHOD: A total of 519 patients with oral cancer in the Ubon Ratchathani Cancer Center were recruited retrospectively over 5 years, from January 1, 2002 to December 31, 2006. The survival status of the patients was followed until December 31, 2007. Survival times were estimated and compared using the product-limit (Kaplan-Meier) method Cox Proportional Hazards models were used to examine prognostic factors.
RESULTS: At the end of the study, 384 patients (74.0%) had died. The mean age of the patients at diagnosis was 64.15 years, with a male to female ratio of 1:1.56. Location of cancer were found at tongue (25.2%), buccal mucosa (22.4%), gum (21.1%), lip (17.5%) and others (13.7%). Squamous cell carcinoma was the most common cell type (92.7%). The median survival time was 337 days and the survival probability at 1, 3 and 5-years were 46.7%, 26.4% and 18.2%, respectively. In multivariable analysis, patients at the greatest risk of death were those having cancer of the tongue (HR 1.93, 1.20, 3.11) compared to cancer of the lip and being in stage IV at diagnosis (HR 3.57, 95% CI = 1.79, 7.13) as compared to stage I.
CONCLUSION: Patients with advanced tumors had the worst prognosis, underscoring the importance of improved early detection for early treatment.

Entities:  

Mesh:

Year:  2010        PMID: 20420101

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  7 in total

1.  COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway.

Authors:  Yan-Hong Wang; Ming-Wei Wu; An-Kui Yang; Wei-Dong Zhang; Jian Sun; Tian-Run Liu; Yan-Feng Chen
Journal:  Med Oncol       Date:  2010-11-11       Impact factor: 3.064

2.  Adjuvant high-dose-rate brachytherapy in the management of oral cavity cancers: 5 years of experience in Iran.

Authors:  Ali Kazemian; Mohammad Babaei; Marzieh Lashkari; Reza Ghalehtaki; Ata Garajei; Maziar Motiee-Langroudi; Ahmadreza Sebzari; Ramin Jaberi; Soraya Gholami; Somayyeh Babaloui; Mahdi Aghili
Journal:  J Contemp Brachytherapy       Date:  2017-08-30

3.  Oral cancer: A multicenter study.

Authors:  P Aminishakib; K Dhanuthai; S Rojanawatsirivej; W Thosaporn; S Kintarak; A Subarnbhesaj; M Darling; E Kryshtalskyj; C-P Chiang; H-I Shin; S-Y Choi; S-S Lee
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2018-01-01

4.  Oral microbial profile in oral cancer patients before and after radiation therapy in a cancer care center - A prospective study.

Authors:  K Anjali; A B Arun; T S Bastian; R Parthiban; M Selvamani; H Adarsh
Journal:  J Oral Maxillofac Pathol       Date:  2020-05-08

5.  Cost-utility analysis of the screening program for early oral cancer detection in Thailand.

Authors:  Chutima Kumdee; Wantanee Kulpeng; Yot Teerawattananon
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

6.  Clinicopathological characteristics predicting advanced stage and surgical margin invasion of oral squamous cell carcinoma: A single-center study on 10 years of cancer registry data.

Authors:  Nur Rahadiani; Muhammad Habiburrahman; Diah Rini Handjari; Marini Stephanie; Ening Krisnuhoni
Journal:  Oncol Lett       Date:  2022-08-31       Impact factor: 3.111

7.  Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma.

Authors:  Shota Saito; Hiroto Yamamoto; Ken-ichi Mukaisho; Sho Sato; Tomoki Higo; Takanori Hattori; Gaku Yamamoto; Hiroyuki Sugihara
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.